Located in Aarhus, Denmark, LCG Biosearch Technologies is a leading provider of custom-manufactured synthetic oligonucleotides across the world. A primary focus of the company is the production of highly-modified synthetic DNA and RNA to serve life science research and healthcare markets.
Supervisor and expertise
Jakob Karaffa, Director of Operations; +10 years of extensive experience with synthesis and purification of highly modified oligos. This includes quantification and characterization of oligos using analytical HPLC / UPLC, LC-MS and fluorescence detection.
Learn more about LGC Biosearch Technologies: https://eu.biosearchtech.com/